| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/19/2006 | US7109319 For treatment of auto-immune and immunde disorders and chronic obstructive pulmonary disease; FAIL is an Fc receptor |
| 09/19/2006 | US7109316 New class of nucleoside triphosphates that contain an oligonucleotide of random or defined sequence attached to the base and are substrates for polymerases and terminal nucleotidyl transferases is described |
| 09/19/2006 | US7109308 Inhibiting tumor growth, inflammation, diabetic retinopathy, rheumatoid arthritis and psoriasis; diagnostic methods for detecting mutations in the VEGF2 coding sequence and alterations in the concentration of VEGF2 protein |
| 09/19/2006 | US7109306 Antibody or fragment that specifically binds to a protein, decrease in the level of mim-1 protein is observed; inhibiting abnormal cell proliferation or differentiation |
| 09/19/2006 | US7109298 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in an HT-29 colon carcinoma cell |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109179 Methods and compositions comprising DNA damaging agents and p53 |
| 09/19/2006 | US7109165 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates |
| 09/19/2006 | US7109029 Adenoviral transcription of colony stimulating factor; gene expression inhibition; antitumor agents; antiproliferative agents; tissue engineering |
| 09/19/2006 | US7109026 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 09/19/2006 | US7109021 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 09/19/2006 | US7108995 Small peptides having apoptotic activities and their applications |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108972 Proteins, polynucleotides encoding them and methods of using the same |
| 09/19/2006 | US7108844 Use of stabilized oligonucleotides for preparing a medicament with antitumor activity |
| 09/19/2006 | CA2248186C Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 09/14/2006 | WO2006096754A2 Stabilized aptamers to psma and their use as prostate cancer therapeutics |
| 09/14/2006 | WO2006096441A2 Reagents, methods and systems to suppress phospholamban expression |
| 09/14/2006 | WO2006095837A1 Lipid membrane structure capable of delivering target substance into mitochondrion |
| 09/14/2006 | WO2006094344A1 Methods and agents for regulating cellular interactions and development |
| 09/14/2006 | WO2006094336A1 Generation of diploid reprogrammed cells through nuclear inactivation |
| 09/14/2006 | WO2006075172A3 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2 |
| 09/14/2006 | WO2006069812A3 Retrotransposon inhibition in therapy |
| 09/14/2006 | WO2006056885A3 Igf-1 isoforms |
| 09/14/2006 | WO2006046017A3 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 09/14/2006 | WO2006023210A3 Gp132: mehods and compositions for treating cancer |
| 09/14/2006 | WO2006020949A3 Combined gene therapy for the treatment of macroscopic gliomas |
| 09/14/2006 | WO2006012304A3 Increasing life span by modulation of smek |
| 09/14/2006 | WO2005115136A3 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases |
| 09/14/2006 | WO2005109000A3 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 09/14/2006 | WO2005074607A3 Method of treating hemolytic disease |
| 09/14/2006 | WO2005067583A8 Immunoliposome-nucleic acid amplication (ilnaa) assay |
| 09/14/2006 | WO2005021583A8 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β |
| 09/14/2006 | WO2005001042A3 Smooth muscle progenitor cells |
| 09/14/2006 | WO2003002721A3 Compositions and methods for inferring a response to a statin |
| 09/14/2006 | US20060206949 Custom-made meganuclease and use thereof |
| 09/14/2006 | US20060205924 Spliced variants of lgr6 |
| 09/14/2006 | US20060205693 Antisense antiviral compounds and methods for treating a filovirus infection |
| 09/14/2006 | US20060205688 Method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205636 Oxytocin as cardiomyogenesis inducer and uses thereof |
| 09/14/2006 | US20060205635 Antigene oligomers inhibit transcription |
| 09/14/2006 | US20060205079 Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors |
| 09/14/2006 | US20060205074 Neural progenitor cells derived from whole bone marrow |
| 09/14/2006 | US20060205069 Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060204982 Novel compositions and methods for cancer |
| 09/14/2006 | US20060204974 Screening agents for post-transcriptional control of angiotensin receptors; hypotensive agents |
| 09/14/2006 | US20060204968 Tools for diagnostics, molecular definition and therapy development for chronic inflammatory joint diseases |
| 09/14/2006 | US20060204967 Methods for identifying risk of breast cancer and treatments thereof |
| 09/14/2006 | US20060204960 Method for diagnosing diffuse-type gastric cancers |
| 09/14/2006 | US20060204584 Materials and methods relating to polyions and substance delivery |
| 09/14/2006 | US20060204566 Novel liposome complexes for increased systemic delivery |
| 09/14/2006 | US20060204537 Silicone blends and composites for drug delivery |
| 09/14/2006 | US20060204523 Flavivirus vaccine delivery system |
| 09/14/2006 | US20060204519 Genetic vaccine for generating immunity to human immunodeficiency virus-1 |
| 09/14/2006 | US20060204514 Expression of hydrophobic proteins |
| 09/14/2006 | US20060204480 Replication competent virus or its recombinant for use in cancer therapy |
| 09/14/2006 | US20060204479 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 09/14/2006 | US20060204478 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/14/2006 | US20060204477 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 09/14/2006 | US20060204476 Treating hepatocellular carcinomas using therapeutic viruses |
| 09/14/2006 | US20060204475 Melan-a peptide analogue-virus-like-particle conjugates |
| 09/14/2006 | US20060204472 Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems |
| 09/14/2006 | CA2601187A1 Novel htmc promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes |
| 09/14/2006 | CA2600951A1 Growth factor mutants with improved biological activity |
| 09/14/2006 | CA2599577A1 Nucleic acids and proteins and methods for making and using them |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700606A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1700120A2 Marker for neuromyelitis optica |
| 09/13/2006 | EP1699925A1 Il-23 and its receptor; related reagents and methods |
| 09/13/2006 | EP1699918A1 High-titer retroviral packaging cells |
| 09/13/2006 | EP1699527A1 High-density lipoprotein coated medical devices |
| 09/13/2006 | EP1699500A1 Crosslinked hyaluronic acid compositions for tissue augmentation |
| 09/13/2006 | EP1699398A2 Enhancement of immune responses |
| 09/13/2006 | EP1485067B1 Materials containing multiple layers of vesicles |
| 09/13/2006 | EP1385452B1 Ophthalmic drug delivery device |
| 09/13/2006 | EP1355655B1 Compositions and methods for improving kidney function |
| 09/13/2006 | EP1305635B1 Methods to identify compounds that modulate rage |
| 09/13/2006 | EP1284720B1 L-fmau for the treatment of hepatitis delta viral infection |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1200067B1 Method for the preparation of microparticles comprising biological material |
| 09/13/2006 | EP1079807B1 Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract |
| 09/13/2006 | EP1007656B1 Modified protein kinase a-specific hybrid oligonucleotide in combination with paclitaxol and methods of their use |
| 09/13/2006 | EP0843732B1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 09/13/2006 | CN1833027A Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 09/13/2006 | CN1833022A Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequence and their therapeutic use |
| 09/13/2006 | CN1832965A Endothelial cell specific antibodies and uses thereof |
| 09/13/2006 | CN1832963A Specific inhibition of allograft rejection |
| 09/13/2006 | CN1832956A Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
| 09/13/2006 | CN1832763A Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |
| 09/13/2006 | CN1831119A Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 09/13/2006 | CN1274821C Modular transport systems for molecular substances and production and use thereof |
| 09/13/2006 | CN1274365C Medicinal compositions for angiogenic therapy |
| 09/12/2006 | US7105656 Compositions and methods for treating hematologic malignancies and multiple drug resistance |
| 09/12/2006 | US7105649 Gene and amplification with polynucleotides having amino acid sequence |
| 09/12/2006 | US7105496 Analyzing tumors; bone disorders; antidiabetic agents; platelet derived endothelial growth factor |